Position in GH
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$6,901
+$6,693 QoQ
Shares Held
46
+1050.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#530
of 594 holders
Holding Since
Jun 2022
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Blue Trust, Inc. holds $5,537,523 across 21 Diagnostics & Research names. GH ranks #19 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DHR |
Danaher Corp /De/
|
6,461 | $1,230,690 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
2,393 | $1,199,753 | |
| 3 | CRL |
Charles River Laboratories International, Inc.
|
2,937 | $666,081 | |
| 4 | QGEN |
Qiagen N.V.
|
15,636 | $611,367 | |
| 5 | MEDP |
Medpace Holdings, Inc.
|
811 | $429,497 | |
| 6 | DGX |
Quest Diagnostics Inc
|
1,090 | $231,024 | |
| 7 | ICLR |
Icon PLC
|
1,132 | $196,639 | |
| 8 | WAT |
Waters Corp /De/
|
445 | $166,891 |
All Filings in GH
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,901 | 46 | Shares | Sole | 2026-07-21 | |
| 2025-06-30 | $208 | 4 | Shares | Sole | 2025-07-24 | |
| 2025-03-31 | $213 | 5 | Shares | Defined | 2025-04-21 | |
| 2023-12-31 | $6 | 176 | Shares | Sole | 2024-01-18 | |
| 2023-06-30 | $35 | 1 | Shares | Sole | 2023-07-14 | |
| 2022-09-30 | $968 | 18 | Shares | Sole | 2022-10-21 | |
| 2022-06-30 | $161 | 4 | Shares | Sole | 2022-08-09 | |
| No filing history on record for this holder in this stock. | ||||||